# Midatech Pharma extends R&D collaboration with Janssen

- Link: https://www.directorstalkinterviews.com/midatech-pharma-extends-rd-collaboration-with-janssen-2/4121056062
- Published: 2022-03-09T07:45:07+00:00
- Author: Amilia Stone

**Midatech Pharma PLC **(LON:MTPH), a drug delivery technology company focused on
improving the bio-delivery and biodistribution of medicines, has announced an extension
of its existing R&D collaboration with Janssen Pharmaceutica NV originally announced
on 21 July 2020.

On 17 June 2021 the Company announced that, using its Q-Sphera technology, it had
successfully encapsulated a proprietary Janssen experimental large molecule medicine
and importantly preserved its functional integrity. The Company believes no other
commercial or academic organisation has been able to successfully deliver any such
experimental medicine over extended periods using methods capable of commercial 
scaling.

Following the initial programme (MTX213), the collaboration has been extended to
include another large molecule to the research performed by Midatech for Janssen.
As with the MTX213 molecule, the work will concentrate on maximizing drug loading
and optimizing _in vitro_ duration of release for this undisclosed Janssen experimental
molecule using the Midatech’s Q-Sphera technology. 

> **Dmitry Zamoryakhin, Chief Scientific Officer of Midatech Pharma, said**:
> “We look forward to working with Janssen and the application of our technology
> specific to this new API.” 

Share on:
